Showing results (2611-2620 of 9,335) with videos related to
Sort By:
Pageof 934
Cancer Medicine|May 12, 2020
Evaluating the eighth edition TNM staging system for esophageal cancer among patients receiving neoadjuvant therapy: A SEER studyYonggang Yuan, Ge Ma, Xuelei Hu, et al.Cancer Medicine|May 14, 2020
Non-genetic biomarkers and colorectal cancer risk: Umbrella review and evidence triangulationXiaomeng Zhang, Dipender Gill, Yazhou He, et al.Cancer Medicine|May 14, 2020
Reverse swing-M, phase 1 study of repurposing mebendazole in recurrent high-grade gliomaVijay M Patil, Arti Bhelekar, Nandini Menon, et al.Cancer Medicine|May 16, 2020
Duration of nivolumab for pretreated, advanced non-small-cell lung cancerMargaux Geier, Renaud Descourt, Romain Corre, et al.Cancer Medicine|June 2, 2020
Noncoding RNA 886 alleviates tumor cellular immunological rejection in host C57BL/C miceHui Ma, Miao Wang, Ying Zhou, et al.Cancer Medicine|June 2, 2020
MRI-based radiomics nomogram to predict synchronous liver metastasis in primary rectal cancer patientsMinglu Liu, Xiaolu Ma, Fu Shen, et al.Cancer Medicine|April 26, 2020
IDH1 and IDH2 mutations in lung adenocarcinomas: Evidences of subclonal evolutionErika F Rodriguez, Federico De Marchi, Parvez M Lokhandwala, et al.Cancer Medicine|April 30, 2020
Bcl-2/Bcl-xl inhibitor APG-1252-M1 is a promising therapeutic strategy for gastric carcinomaHanjie Yi, Miao-Zhen Qiu, Luping Yuan, et al.Cancer Medicine|April 30, 2020
The underlying mechanisms of lorlatinib penetration across the blood-brain barrier and the distribution characteristics of lorlatinib in the brainWei Chen, Dujia Jin, Yafei Shi, et al.Cancer Medicine|May 21, 2020
Stromal score as a prognostic factor in primary gastric cancer and close association with tumor immune microenvironmentMin Mao, Qingliang Yu, Rongzhi Huang, et al.Pageof 934